Mwanzo1SXP • ETR
add
SCHOTT Pharma AG & Co KgaA
Bei iliyotangulia
€ 28.10
Bei za siku
€ 28.10 - € 28.70
Bei za mwaka
€ 18.50 - € 36.88
Thamani ya kampuni katika soko
4.28B EUR
Wastani wa hisa zilizouzwa
elfu 43.47
Uwiano wa bei na mapato
28.74
Mgao wa faida
0.57%
Ubadilishanaji wa msingi
ETR
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 252.33M | 7.74% |
Matumizi ya uendeshaji wa biashara | 34.03M | -36.39% |
Mapato halisi | 38.44M | 53.55% |
Kiwango cha faida halisi | 15.23 | 42.47% |
Mapato kwa kila hisa | 0.26 | 52.94% |
EBITDA | 68.77M | 66.05% |
Asilimia ya kodi ya mapato | 22.72% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 26.09M | 37.21% |
Jumla ya mali | 1.49B | 9.32% |
Jumla ya dhima | 646.91M | 2.53% |
Jumla ya hisa | 838.82M | — |
hisa zilizosalia | 150.61M | — |
Uwiano wa bei na thamani | 5.06 | — |
Faida inayotokana na mali | 8.38% | — |
Faida inayotokana mtaji | 10.92% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 38.44M | 53.55% |
Pesa kutokana na shughuli | 48.03M | 88.89% |
Pesa kutokana na uwekezaji | -29.32M | -2.59% |
Pesa kutokana na ufadhili | -9.97M | -1,287.38% |
Mabadiliko halisi ya pesa taslimu | 9.31M | 500.73% |
Mtiririko huru wa pesa | 37.00M | 139.76% |
Kuhusu
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Ilianzishwa
1 Ago 2022
Tovuti
Wafanyakazi
4,790
